Report: billionaire Sackler family, accused of encouraging the opioid epidemic

Report: billionaire Sackler family, accused of encouraging the opioid epidemic

  • September 11, 2018
Table of Contents

Report: billionaire Sackler family, accused of encouraging the opioid epidemic

The Sackler family owns Purdue Pharma, which created the infamous opioid painkiller OxyContin Richard Sackler and his billionaire family, who have been blamed for fosteringthe nation’s ongoing opioid epidemic, owna second pharmaceutical company. The Sacklers are the owners of Purdue Pharma, which created the addictive opioid painkiller OxyContin. But the family alsoowna second company based in Rhode Island, Rhodes Pharma, according to a Financial Times report released Sunday.

Rhodes Pharma is of one of the largest creators of off-patent generic opioids. The company produces several opioid-based painkillers that contain addictive drugs including oxycodone, hydrocodone and morphine. Rhodes Pharma was started in 2007, according to companyregistration documents obtained by the Financial Times.

Purdue Pharma and Rhodes Pharma combined were responsible for 14.4 million opioid prescriptions in theU.S. The Sacklers are worth a combined$13 billion, according to a 2016 Forbes report. Thevast majority of their wealth, shared among 20 family members, is derived fromdrug-making. Purdue Pharma has faced hundreds of lawsuits over the years for fueling the opioid epidemic.

More than 63,000 people in the U.S. died from drug overdoses in 2016, of which 66 percent were related to opioid use. The lawsuit also said Purdue Pharma’s marketing not only “exaggerated the benefits” of the medication but the company also told medical practitioners that they were in jeopardy of violating theHippocratic Oath if they didn’t treat patients suffering from certain conditions with opioids.

Source: newsweek.com

Tags :
Share :
comments powered by Disqus

Related Posts

AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More
Cancer cells engineered with CRISPR slay their own kin

Cancer cells engineered with CRISPR slay their own kin

Using gene editing, scientists have hoodwinked tumor cells into turning against their own kind. Cancer cells circulating in the bloodstream have something of a homing instinct, able to find and return to the tumor where they originated. To capitalize on that ability, researchers engineered these roving tumor cells to secrete a protein that triggers a death switch in resident tumor cells they encounter.

Read More
First ever color X-ray on a human

First ever color X-ray on a human

New Zealand scientists have performed the first-ever 3-D, colour X-ray on a human, using a technique that promises to improve the field of medical diagnostics, said Europe’s CERN physics lab which contributed imaging technology. The new device, based on the traditional black-and-white X-ray, incorporates The CERN technology, dubbed Medipix, works like a camera detecting and counting individual sub-atomic particles as they collide with pixels while its shutter is open.

Read More